Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Recent Patents on Anti-Cancer Drug Discovery|February 22, 2008
Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancerRamzi Mohammad, Anshu Giri, Anton-Scott Goustin
Cellular Signalling|November 20, 2010
The "thrifty" gene encoding Ahsg/Fetuin-A meets the insulin receptor: Insights into the mechanism of insulin resistanceAnton-Scott Goustin, Abdul B Abou-Samra
Cellular Signalling|January 15, 2013
Ahsg-fetuin blocks the metabolic arm of insulin action through its interaction with the 95-kD β-subunit of the insulin receptorAnton Scott Goustin, Nada Derar, Abdul B Abou-Samra
Non-Coding RNA|September 20, 2019
The Growth-Arrest-Specific (GAS)-5 Long Non-Coding RNA: A Fascinating lncRNA Widely Expressed in CancersAnton Scott Goustin, Pattaraporn Thepsuwan, Mary Ann Kosir, et al.
Molecular and Cellular Biology|April 17, 2003
Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycleSylvia C Dryden, Fatimah A Nahhas, James E Nowak, et al.
Journal of Immunological Methods|March 22, 2005
Sheep red blood cells armed with anti-CD20 single-chain variable fragments (scFvs) fused to a glycosylphosphatidylinositol (GPI) anchor: a strategy to target CD20-positive tumor cellsNayera Hamdy, Anton Scott Goustin, Jean-Paul Desaulniers, et al.
Journal of Hematology & Oncology|February 18, 2009
SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation statusAyad M Al-Katib, Yuan Sun, Anton Scott Goustin, et al.
Frontiers in Genetics|December 9, 2021
Gestational Age Dependence of the Maternal Circulating Long Non-Coding RNA Transcriptome During Normal Pregnancy Highlights Antisense and Pseudogene TranscriptsErica L Kleinbrink, Nardhy Gomez-Lopez, Donghong Ju, et al.
Genomics|July 2, 2022
Estrogen distinctly regulates transcription and translation of lncRNAs and pseudogenes in breast cancer cellsSiew-Woh Choo, Yu Zhong, Edward Sendler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1Ramzi M Mohammad, Anton Scott Goustin, Amro Aboukameel, et al.
Pageof 2